Elevated neurotrophin-3 and neurotrophin 4/5 levels in unmedicated bipolar depression and the effects of lithium

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 56, Issue , 2015, Pages 243-246

  Loch, Alexandre A ^a   Zanetti, Marcus V ^a   de Sousa, Rafael T ^a   Chaim, Tiffany M ^a   Serpa, Mauricio H ^a   Gattaz, Wagner F ^a   Teixeira, Antonio L ^c   Machado Vieira, Rodrigo ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c Faculty of Medical Sciences of Minas Gerais   (Brazil)

Author keywords

Biomarkers; Bipolar disorder; Lithium; Neurotrophic; Treatment

Indexed keywords

LITHIUM; NEUROTROPHIN 3; NEUROTROPHIN 4; LITHIUM CHLORIDE; NERVE GROWTH FACTOR; NEUROTROPHIN-3, HUMAN; TRANQUILIZER;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG RESPONSE; FEMALE; HUMAN; MALE; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; ADOLESCENT; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; BLOOD; MIDDLE AGED; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTIMANIC AGENTS; BIPOLAR DISORDER; FEMALE; HUMANS; LITHIUM CHLORIDE; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84908181071     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.09.014     Document Type: Article

References (32)

1. Agerman K., Ernfors P. Differential influence of BDNF and NT3 on the expression of calcium binding proteins and neuropeptide Y in vivo. Neuroreport 2003, 14(17):2183-2187. 10.1097/01.wnr.0000095710.83808.57.
2. Altar C.A. Neurotrophins and depression. Trends Pharmacol Sci 1999, 20(2):59-61.
3. Andreazza A.C., Kauer-Sant'anna M., Frey B.N., Bond D.J., Kapczinski F., Young L.T., et al. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 2008, 111(2-3):135-144. 10.1016/j.jad.2008.04.013.
4. Barbosa I.G., Morato I.B., Huguet R.B., Rocha F.L., Machado-Vieira R., Teixeira A.L. Decreased plasma neurotrophin-4/5 levels in bipolar disorder patients in mania. Rev Bras Psiquiatr 2014, [Epub ahead of print]. 10.1590/1516-4446-2014-1380.
5. Begliuomini S., Casarosa E., Pluchino N., Lenzi E., Centofanti M., Freschi L., et al. Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod 2007, 22(4):995-1002. 10.1093/humrep/del479.
6. Berk M., Kapczinski F., Andreazza A.C., Dean O.M., Giorlando F., Maes M., et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011, 35(3):804-817. 10.1016/j.neubiorev.2010.10.001.
7. Braga W.S., Borges F.G., Barros Junior G.M., Martinho A.C., Rodrigues I.S., Azevedo E.P., et al. Prevalence of hepatitis A virus infection: the paradoxical example of isolated communities in the western Brazilian Amazon region. Rev Soc Bras Med Trop 2009, 42(3):277-281.
8. Bus B.A., Molendijk M.L., Penninx B.J., Buitelaar J.K., Kenis G., Prickaerts J., et al. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 2011, 36(2):228-239.
9. Cheng B., Mattson M.P. NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res 1994, 640(1-2):56-67.
10. Cheng B., Goodman Y., Begley J.G., Mattson M.P. Neurotrophin-4/5 protects hippocampal and cortical neurons against energy deprivation- and excitatory amino acid-induced injury. Brain Res 1994, 650(2):331-335.
11. de Sousa R.T., van de Bilt M.T., Diniz B.S., Ladeira R.B., Portela L.V., Souza D.O., et al. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study. Neurosci Lett 2011, 494(1):54-56. 10.1016/j.neulet.2011.02.054.
12. de Sousa R.T., Zarate C.A., Zanetti M.V., Costa A.C., Talib L.L., Gattaz W.F., et al. Oxidative stress in early stage bipolar disorder and the association with response to lithium. J Psychiatr Res 2014, 50:36-41. 10.1016/j.jpsychires.2013.11.011.
13. Duman R.S. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 2004, 5(1):11-25. 10.1385/NMM:5:1:011.
14. Fernandes B.S., Gama C.S., Walz J.C., Cereser K.M., Fries G.R., Colpo G., et al. Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes. J Psychiatr Res 2010, 44(9):561-565. 10.1016/j.jpsychires.2009.11.020.
15. Fernandes B.S., Gama C.S., Cereser K.M., Yatham L.N., Fries G.R., Colpo G., et al. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 2011, 45(8):995-1004. 10.1016/j.jpsychires.2011.03.002.
16. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., National Institute of Mental Health (U.S.) User's guide for the structured clinical interview for DSM-IV axis I disorders SCID-I clinician version 1997, American Psychiatric Press, Inc., Washington, DC.
17. Giehl K.M., Rohrig S., Bonatz H., Gutjahr M., Leiner B., Bartke I., et al. Endogenous brain-derived neurotrophic factor and neurotrophin-3 antagonistically regulate survival of axotomized corticospinal neurons in vivo. J Neurosci 2001, 21(10):3492-3502.
18. Hashimoto K., Shimizu E., Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 2004, 45(2):104-114. 10.1016/j.brainresrev.2004.02.003.
19. Huang E.J., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001, 24:677-736. 10.1146/annurev.neuro.24.1.677.
20. Hyman C., Juhasz M., Jackson C., Wright P., Ip N.Y., Lindsay R.M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J Neurosci 1994, 14(1):335-347.
21. Kapczinski F., Frey B.N., Kauer-Sant'Anna M., Grassi-Oliveira R. Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother 2008, 8(7):1101-1113. 10.1586/14737175.8.7.1101.
22. Lu B., Figurov A. Role of neurotrophins in synapse development and plasticity. Rev Neurosci 1997, 8(1):1-12.
23. Machado-Vieira R., Dietrich M.O., Leke R., Cereser V.H., Zanatto V., Kapczinski F., et al. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol Psychiatry 2007, 61(2):142-144. 10.1016/j.biopsych.2006.03.070.
24. Machado-Vieira R., Soeiro-De-Souza M.G., Richards E.M., Teixeira A.L., Zarate C.A. Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach. World J Biol Psychiatry 2013, 10.3109/15622975.2013.830775.
25. Molendijk M.L., Haffmans J.P., Bus B.A., Spinhoven P., Penninx B.W., Prickaerts J., et al. Serum BDNF concentrations show strong seasonal variation and correlations with the amount of ambient sunlight. PLoS One. 2012, 7(11):e48046.
26. Pan W., Banks W.A., Kastin A.J. Permeability of the blood-brain barrier to neurotrophins. Brain Res 1998, 788(1-2):87-94.
27. Sauer H., Wong V., Bjorklund A. Brain-derived neurotrophic factor and neurotrophin-4/5 modify neurotransmitter-related gene expression in the 6-hydroxydopamine-lesioned rat striatum. Neuroscience 1995, 65(4):927-933.
28. Scola G., Andreazza A.C. The role of neurotrophins in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2014, 10.1016/j.pnpbp.2014.08.013.
29. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002, 22(8):3251-3261. [doi:20026292].
30. Walz J.C., Andreazza A.C., Frey B.N., Cacilhas A.A., Cereser K.M., Cunha A.B., et al. Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder. Neurosci Lett 2007, 415(1):87-89. 10.1016/j.neulet.2007.01.002.
31. Walz J.C., Frey B.N., Andreazza A.C., Cereser K.M., Cacilhas A.A., Valvassori S.S., et al. Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania. J Psychiatr Res 2008, 42(5):416-421. 10.1016/j.jpsychires.2007.03.005.
32. Walz J.C., Magalhaes P.V., Giglio L.M., Cunha A.B., Stertz L., Fries G.R., et al. Increased serum neurotrophin-4/5 levels in bipolar disorder. J Psychiatr Res 2009, 43(7):721-723. 10.1016/j.jpsychires.2008.10.005.